She pointed out that FIS had erred in not recognizing the Prohibited Substance Dexamethason as a Specified Substance.
On 14 July 2005, the Secretary General of FIS sent a letter to the CAS stating that the FIS Doping Panel had issued a new decision acknowledging that the substance Dexamethason was a Specified Substance.
In addition to the erroneous classification of Dexamethason, the FIS Doping Panel subsequently erred in its unilateral and procedurally incorrect attempt to remedy the error.
The Appellant has disclosed and substantiated her defence that Dexamethason was not intended to enhance performance.
The Appellant acted negligently in not inquiring whether Dexamethason fell within the category of "all glucocorticosteroids" either under Group S9 of the WADA Prohibited List or on the Specified Substance list.